Insider Transactions Reported by 17 Insiders of Estrella Immunopharma, Inc.

Symbol
ESLA, ESLAW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
Emeryville, CA

There are no Buy or Sell transactions made by insiders since 12/15/2024

Estrella Immunopharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Hong Zhang Director, Chairperson of the Board Aug 14, 2024
TradeUP Acquisition Sponsor LLC Former 10% owner Sep 29, 2023
Dengyao Jia Director Sep 22, 2025
Owl Creek Asset Management, L.P. 10%+ Owner Sep 29, 2023
Eureka Therapeutics, Inc. 10%+ Owner Sep 29, 2023
Jianwei Li Former Co-CEO and Director Sep 29, 2023
Weston Twigg Former Director Sep 29, 2023
Jiandong Xu Chief Financial Officer Oct 30, 2024
Cheng Liu Chief Executive Officer, Director Oct 30, 2024
Tao Jiang Former Director Sep 29, 2023
Weiguang Yang Former Co-CEO and Director Sep 29, 2023
Luqi Wen Former CFO Sep 29, 2023
James Long Former Director Sep 29, 2023
Fan Wu Director Sep 29, 2023
Xuejun Janelle Wu Director Sep 29, 2023
Pei Xu Director Sep 29, 2023
Marsha Roberts Director Sep 29, 2023

Recent Insider Transactions by Companies or Individuals for Estrella Immunopharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.